US FDA's New Paragraph IV Data Further Illustrates Generic Competition Problems

Generics
The US FDA is releasing more patent-related information for generic drug sponsors. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Generics

More from Biosimilars & Generics